文献速递中枢神经肿瘤放疗姑息放疗与转移瘤放疗物理与技术

基于全国医疗保险数据的脑转移瘤治疗费用分析

Cost of Treatment for Brain Metastases Using Data From a National Health Insurance.
PubMed 文献 · Adv Radiat Oncol · 2024-02-01

该研究分析2020年1月1日至2022年7月1日期间Highmark Health保险覆盖的宾夕法尼亚、特拉华、西弗吉尼亚和纽约州1048例脑转移瘤患者的医疗索赔数据。结果显示全脑放疗每次治疗费用最低(5225美元),海马保护调强放疗最高(47748美元),伽玛刀与直线加速器立体定向放射外科每次治疗费用相近。

要点

  • 全脑放疗每次治疗费用最低,为5225美元。
  • 海马保护调强放疗每次治疗费用最高,为47748美元。
  • 伽玛刀与直线加速器立体定向放射外科每次治疗费用相近(30711 vs 30737美元)。

核心结论

  • 全脑放疗是费用最低的放射治疗技术。
  • 伽玛刀与直线加速器立体定向放射外科每次治疗价格相似,支持两者用于脑转移瘤治疗。
  • 立体定向放疗总体上每次使用费用高于立体定向放射外科,需对其频繁使用进一步审视。
  • 海马保护调强放疗每次使用费用最高,且高出幅度中等,需进一步讨论其与其他放疗模式的成本效益比较。

研究设计与样本

  • 研究分析2020年1月1日至2022年7月1日期间Highmark Health保险覆盖的宾夕法尼亚、特拉华、西弗吉尼亚和纽约州诊断为脑转移瘤(ICD-10编码C79.31)并接受放射治疗患者的医疗索赔数据,共1048例。
  • 费用按特定现行 Procedural Terminology 索赔代码分组,并细分为技术部分和医师部分,部分模式区分医院与独立中心费用。

主要发现

  • 1048例Highmark Health会员接受脑转移瘤治疗,女性592例显著多于男性456例,平均年龄64.4岁。
  • 每名会员平均有5.309次索赔,每次索赔平均费用2015美元,总费用为10,697,749美元。
  • 每次治疗分析显示海马保护调强放疗费用最高,为47,748美元,其次为立体定向放疗37,230美元、直线加速器立体定向放射外科30,737美元、伽玛刀立体定向放射外科30,711美元、全脑放疗5225美元。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: In the United States, brain metastases (BMs) affect 10% to 20% of patients with cancer, presenting a significant health care challenge and necessitating intricate, high-cost treatments. Few studies have explored the comprehensive care cost for BMs, and none have used real insurance claims data. Partnering with a northeastern health care insurer, we investigated the true costs of various brain-directed radiation methods, aiming to shed light on treatment expenses, modalities, and their efficacy. METHODS AND MATERIALS: We analyzed medical claims from Highmark Health-insured patients in Pennsylvania, Delware, West Virginia, and New York diagnosed with BMs (ICD-10 code C79.31) and treated with radiation from January 1, 2020 to July 1, 2022. Costs for radiation techniques were grouped by specific current procedural terminology claim codes. We subdivided costs into technical and physician components and separated hospital from freestanding costs for some modalities. RESULTS: From January 1, 2020 to July 1, 2022, 1048 Highmark Health members underwent treatment for BMs. Females (n = 592) significantly outnumbered males (n = 456), with an average age of 64.4 years. Each member had, on average, 5.309 claims costing $2015 per claim. Total cost totaled $10,697,749. Per-treatment analysis showed that hippocampal avoidance intensity modulated radiation therapy was the costliest treatment at $47,748, followed by stereotactic radiation therapy at $37,230, linear accelerator stereotactic radiosurgery (SRS) at $30,737, Gamma Knife SRS at $30,711, and whole-brain radiation therapy at $5225. CONCLUSIONS: Whole-brain radiation therapy was the least costly radiation technique. Similar per-treatment prices for Gamma Knife and linear accelerator SRS support their use in treating BMs. Stereotactic radiation therapy in general was costlier on a per-use basis than SRS, prompting further scrutiny on its frequent use. Hippocampal avoidance intensity modulated radiation therapy was the costliest radiation therapy on a per-use basis by a moderate amount, prompting further discussion about its comparative cost effectiveness against other radiation modalities. This study underscores the importance of multiple considerations in treating BMs, such as tumor control, survival, side effects, and costs.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Crooks J, Dominic O, Shepard M, et al. Cost of Treatment for Brain Metastases Using Data From a National Health Insurance. Adv Radiat Oncol. 2024. PMID: 38567144. doi:10.1016/j.adro.2024.101438

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。